Having demonstrated the high proportion of ITGA1/ITGA2 copy loss/del in metastatic PCa tumors overrepresenting metastasis pathways (Figure 1f–h), we proceeded to investigate the effect of ITGA1/ITGA2 copy number loss/del on patient metastatic progression outcomes. Here, ITGA2 is linked to posterior cortical atrophy.